Adicet Bio, Inc. (ACET) vs Oncolytics Biotech Inc. (ONCY)
A side-by-side comparison of Adicet Bio, Inc. and Oncolytics Biotech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACET
Adicet Bio, Inc.
$6.38HealthcareDelayed quote: Oct 6, 2026, 1:29 PM EDT
ONCY
Oncolytics Biotech Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 1:24 PM EDT
Total return — ACET vs ONCY
growth of $100 · dividends reinvested · last 9yACET -99.7% (-46.8%/yr)ONCY -91.3% (-23.7%/yr)ONCY compounded faster over this window
Log scale — wide-divergence pair
ACET ONCY
ACET vs ONCY: by the numbers
- •ONCY is the larger company ($60M vs $60M market cap).
Metrics side by side
Valuation
| Metric | ACET | ONCY |
|---|---|---|
| P/B ratio | 0.50 | N/A |
Profitability
| Metric | ACET | ONCY |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -82.38% | N/A |
| ROIC | -79.68% | -1235.48% |
Growth (annualized)
| Metric | ACET | ONCY |
|---|---|---|
| Total return CAGR (5Y) | -44.24% | -21.00% |
Frequently asked
- How have ACET and ONCY total returns compared?
- Over the past 5 years, ACET delivered -44.24% and ONCY delivered -21.00% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.